FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

699679004: Abiraterone acetate (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2014. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
2985662014 Abiraterone acetate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
2985865013 Abiraterone acetate (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
39001000188113 abiratérone acétate fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
788571000172113 acétate d'abiratérone fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Abiraterone acetate Is a Abiraterone false Inferred relationship Some
Abiraterone acetate This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Androgen receptor antagonist (disposition) false Inferred relationship Some
Abiraterone acetate Is a Substance with steroid structure and androgen receptor antagonist mechanism of action false Inferred relationship Some
Abiraterone acetate This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. Abiraterone true Inferred relationship Some
Abiraterone acetate Is a Substance with androgen receptor antagonist mechanism of action false Inferred relationship Some
Abiraterone acetate Is a Substance with steroid structure and androgen synthesis inhibitor mechanism of action (substance) true Inferred relationship Some
Abiraterone acetate This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Androgen synthesis inhibitor true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Abiraterone acetate 250 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Abiraterone acetate Inferred relationship Some
Product containing abiraterone acetate The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Abiraterone acetate Inferred relationship Some
Abiraterone acetate 250 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Abiraterone acetate Inferred relationship Some 1
Abiraterone acetate 250 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Abiraterone acetate Inferred relationship Some 1
Abiraterone acetate 250 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Abiraterone acetate Inferred relationship Some 1
Product containing precisely abiraterone acetate 500 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Abiraterone acetate Inferred relationship Some 1
Product containing precisely abiraterone acetate 500 milligram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Abiraterone acetate Inferred relationship Some 1
Product containing precisely abiraterone acetate 1 gram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Abiraterone acetate Inferred relationship Some 1
Product containing precisely abiraterone acetate 1 gram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Abiraterone acetate Inferred relationship Some 1

This concept is not in any reference sets

Back to Start